Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by greentundraon May 27, 2016 1:18pm
92 Views
Post# 24910900

RE:RE:RE:RE:Quarterly results

RE:RE:RE:RE:Quarterly resultsDisagree and you and Billy are showing your lack of business acumen.
  • The 3,000 patiens is WELL below what they anticipated and 3,000 patients means nothing. How many are active patients and what is the revenue per patient? Unti we get real metrics this is Booth and his half a** marketing team buying time.
  • Webiste, they spent 300k and 18 months building an OK webiste / ERP portal which should become main driver for biz so critical
  • Levy, Booth cash strapped, has both a corporate and personal lawsuit with Levy to defend so whenever the CEO has to take eye off ball, never good - trust me the Levy effect is why ACB is sub 50 cents today.
  • You all need to hold the Csuite accountable for your investment and ALL is not rosy. If it was SP would be north of 80 cents and steadily climbing.
  • Qtrly report will be a mess and I just hope there are some positive nuggets in there to hold on to
  • As for my position, I have traded over 300,000 shares of ACB this week which is ususal and over 600,000 shares long+++
Bullboard Posts